Becton Dickinson and (BDX) DIvidends Date & History

Key Takeaways

• BDX offers a current dividend yield of approximately 2.54% with an annual dividend of $4.20 per share paid quarterly.
• The company has increased its dividend for 54 consecutive years, establishing it as a reliable dividend growth stock.
• Payout ratio exceeds 100%, signaling potential sustainability concerns despite strong free cash flow generation.
• Dividend growth has averaged around 5% annually over the past decade, supporting long-term income expansion.
• Relative to healthcare peers, BDX’s yield is competitive but not the highest in the sector.
• Suitable primarily for dividend growth investors seeking stability in the medical technology space.

Dividend Overview

Becton, Dickinson and Company (BDX) maintains a quarterly dividend payment schedule. The current annual dividend stands at $4.20 per share, delivering a yield near 2.54%. This profile positions BDX as a dividend growth stock rather than a high-yield offering. The company focuses on consistent increases supported by its established position in medical devices and diagnostics. Investors view the modest yield as part of a broader strategy emphasizing long-term dividend expansion over immediate high income.

Dividend History and Growth

BDX has raised its dividend annually for 54 consecutive years. Historical data shows annualized growth rates of approximately 5.03% over the past 12 months and 5.19% over the past decade. Payments have remained consistent without cuts, reflecting a disciplined approach to shareholder returns. The company has steadily lifted the quarterly payout from lower levels in prior years to the current $1.05 per share, aligning with earnings growth and operational performance in the healthcare sector.

Dividend Sustainability and Payout Ratio

The payout ratio for BDX currently stands above 100%, which warrants monitoring for long-term sustainability. Despite this metric, the company generates substantial free cash flow that supports dividend coverage. Debt levels remain manageable within the healthcare industry context, and earnings provide adequate backing for ongoing payments. Overall financial stability appears solid, though investors should watch earnings trends to ensure continued coverage without excessive reliance on debt or reserves.

Dividend Compared to Industry Peers

In the healthcare sector, BDX’s yield of about 2.54% compares favorably to some medical equipment peers but trails higher-yielding names such as certain pharmaceutical companies. Competitors often post yields between 1.5% and 3.5%, depending on business models. BDX stands out for its extended dividend growth streak, which exceeds many peers and appeals to investors prioritizing consistency over maximum current yield.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.

Is This Stock Attractive for Dividend Investors?

BDX may appeal to dividend growth investors who prioritize long-term income increases and stability over high current yields. Its 54-year track record of annual raises and position in essential healthcare products provide a defensive profile suitable for conservative, long-term portfolios. Income-focused investors seeking higher immediate yields might find better options elsewhere in the sector. The stock suits those comfortable with a moderate payout ratio and the company’s ability to sustain growth through earnings and cash flow. Overall, BDX offers a balanced dividend profile for patient investors building positions over time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations